Comparative Bioavailability Study of Omexa Sumatriptan vs. Imitrex® in Healthy Volunteers
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
the trial is a randomized, open label, crossover, single-administration bioavailability study
to compare the pharmacokinetic parameters of Omexa sumatriptan transmucosal sublingual tablet
versus commercial Imitrex® sumatriptan oral tablet in 14 healthy volunteers.